ALNY : Alnylam Pharmaceuticals stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-05-28 |
|---|---|---|---|---|
| 2026 | $310.76 | $300.1 | $321.5 | 1.87% |
| 2027 | $370.17 | $323.59 | $410.49 | 21.34% |
| 2028 | $445.11 | $409.53 | $488.36 | 45.91% |
| 2029 | $521.77 | $494.87 | $552.92 | 71.04% |
| 2030 | $583.31 | $559.53 | $600.89 | 91.21% |
| 2031 | $462.38 | $370.89 | $576.49 | 51.57% |
| 2032 | $407.37 | $365.94 | $432.3 | 33.54% |
| 2033 | $338.56 | $278.34 | $361.78 | 10.98% |
| 2034 | $219.77 | $194.65 | $265.32 | -27.96% |
| 2035 | $149.73 | $126.56 | $191.37 | -50.92% |
| 2036 | $125.96 | $125.44 | $126.26 | -58.71% |
The 19 Wall Street analysts offering Alnylam Pharmaceuticals stock forecast in the last 6 months have average price target of
$448.11 with a high forecast of $527.0 and a low forecast of $330.0.
The average Alnylam Pharmaceuticals stock forecast represents a 46.89%
increase from the last price of $305.059997558594.
For Alnylam Pharmaceuticals stock forecast for 2026, 7 predictions are offered for each month of 2026 with average Alnylam Pharmaceuticals stock
forecast of $310.76, a high forecast of $321.5, and a low forecast of $300.1.
The average Alnylam Pharmaceuticals stock forecast 2026 represents a 1.87%
increase from the last price of $305.059997558594.
For Alnylam Pharmaceuticals stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Alnylam Pharmaceuticals stock
forecast of $370.17, a high forecast of $410.49, and a low forecast of $323.59.
The average Alnylam Pharmaceuticals stock forecast 2027 represents a 21.34%
increase from the last price of $305.059997558594.
For Alnylam Pharmaceuticals stock forecast for 2029, 12 predictions are offered for each month of 2029 with average Alnylam Pharmaceuticals stock
forecast of $521.77, a high forecast of $552.92, and a low forecast of $494.87.
The average Alnylam Pharmaceuticals stock forecast 2029 represents a 71.04%
increase from the last price of $305.059997558594.
For Alnylam Pharmaceuticals stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average Alnylam Pharmaceuticals stock
forecast of $462.38, a high forecast of $576.49, and a low forecast of $370.89.
The average Alnylam Pharmaceuticals stock forecast 2031 represents a 51.57%
increase from the last price of $305.059997558594.
For Alnylam Pharmaceuticals stock forecast 2032, 12 predictions are offered for each month of 2032 with average Alnylam Pharmaceuticals stock
forecast of $407.37, a high forecast of $432.3, and a low forecast of $365.94.
The average Alnylam Pharmaceuticals stock forecast 2032 represents a 33.54%
increase from the last price of $305.059997558594.
For Alnylam Pharmaceuticals stock forecast for 2036 (10 year), 5 predictions are offered for each month of 2036 with average Alnylam Pharmaceuticals stock
forecast of $125.96, a high forecast of $126.26, and a low forecast of $125.44.
The average Alnylam Pharmaceuticals stock forecast 2036 represents a -58.71%
decrease from the last price of $305.059997558594.
Please, see more forecasts below.
ALNY : Alnylam Pharmaceuticals stock forecast by Wall Street Analysts
The average Alnylam Pharmaceuticals stock forecast from last 6 month is $448.11, and this show a -8.13% decrease in average from the prior price target of the each prediction. Also, this average forecast of $448.11 represents a -7.95% decrease from the past average forecast of $486.82, 6 months ago from 38 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2026-05-19 | Citigroup | $380.0000 | Buy | |
| 2026-05-05 | HC Wainwright & Co. | $510.00 | $510.0000 | Buy |
| 2026-05-01 | RBC Capital | $450.0000 | $445.0000 | Outperform |
| 2026-05-01 | Wells Fargo | $376.00 | $377.0000 | Equal-Weight |
| 2026-04-13 | Truist Securities | $515.0000 | $505.0000 | Buy |
| 2026-03-25 | Chardan Capital | $425.00 | $425.00 | Buy |
| 2026-03-25 | HC Wainwright & Co. | $510.00 | $510.0000 | Buy |
| 2026-03-16 | Jefferies | $522.0000 | $330.0000 | Hold |
| 2026-02-18 | HC Wainwright & Co. | $510.00 | $510.0000 | Buy |
| 2026-02-17 | Canaccord Genuity | $415.00 | $429.0000 | Buy |
| 2026-02-17 | Freedom Broker | $470.00 | $410.0000 | Buy |
| 2026-02-13 | Chardan Capital | $475.0000 | $425 | Buy |
| 2026-02-12 | Needham | $529.00 | $510.0000 | Buy |
| 2026-01-30 | HC Wainwright & Co. | $570.0000 | $510.0000 | Buy |
| 2026-01-30 | B of A Securities | $529.00 | $462.0000 | Buy |
| 2026-01-30 | Morgan Stanley | $495.0000 | $408.0000 | Equal-Weight |
| 2026-01-28 | Barclays | $527.0000 | Overweight | |
| 2026-01-20 | Wells Fargo | $479.00 | $376.0000 | Equal-Weight |
| 2026-01-20 | RBC Capital | $500.00 | $465.0000 | Outperform |
| 2026-01-12 | Needham | $520.0000 | $529.0000 | Buy |
| 2026-01-12 | B of A Securities | $530.0000 | $529.0000 | Buy |
| 2026-01-08 | Truist Securities | $535.00 | $530.0000 | Buy |
| 2025-12-15 | Leerink Partners | $370.0000 | $351.0000 | Market Perform |
| 2025-12-11 | Stifel | $495.00 | $508.0000 | Buy |
| 2025-11-11 | Wells Fargo | $395.00 | $479.0000 | Equal-Weight |
| 2025-11-05 | Freedom Broker | $230.0000 | $470.0000 | Buy |
| 2025-10-31 | Piper Sandler | $449.00 | $489 | Overweight |
| 2025-10-31 | Barclays | $460.00 | $527.0000 | Overweight |
| 2025-10-30 | Jefferies | $550.00 | $549.0000 | Buy |
| 2025-10-17 | Truist Securities | $459.0000 | $535.0000 | Buy |
| 2025-10-13 | JP Morgan | $475.00 | $473.0000 | Overweight |
| 2025-10-10 | HC Wainwright & Co. | $570.0000 | $570.0000 | Buy |
| 2025-10-06 | Stifel | $441.0000 | $495.0000 | Buy |
| 2025-10-06 | Morgan Stanley | $405.00 | $475.0000 | Equal-Weight |
| 2025-09-19 | RBC Capital | $435.0000 | $500.0000 | Outperform |
| 2025-09-17 | B of A Securities | $453.0000 | $520 | Buy |
| 2025-09-16 | Goldman Sachs | $504.0000 | $566 | Buy |
| 2025-09-15 | Jefferies | $453.0000 | $550.0000 | Buy |
| 2025-09-11 | Evercore ISI Group | $280.0000 | $515.0500 | Outperform |
| 2025-09-08 | BMO Capital | $450.0000 | $470 | Outperform |
| 2025-09-02 | Citigroup | $527.0000 | $583.0000 | Buy |
| 2025-09-02 | HC Wainwright & Co. | $570.0000 | $570.0000 | Buy |
| 2025-08-07 | HC Wainwright & Co. | $500.0000 | $570.0000 | Buy |
| 2025-08-06 | JP Morgan | $348.00 | $475.0000 | Overweight |
| 2025-08-04 | Wolfe Research | Peer Perform | ||
| 2025-08-04 | Oppenheimer | $490 | Outperform | |
| 2025-08-01 | UBS | $403.0000 | $550.0000 | Buy |
| 2025-08-01 | Canaccord Genuity | $390.00 | $415.0000 | Buy |
| 2025-08-01 | Wells Fargo | $333.00 | $395.0000 | Equal-Weight |
| 2025-08-01 | Raymond James | $370.0000 | $424 | Outperform |
| 2025-08-01 | Barclays | $329.00 | $460.0000 | Overweight |
| 2025-08-01 | Piper Sandler | $304.0000 | $449 | Overweight |
| 2025-08-01 | Chardan Capital | $325.00 | $400 | Buy |
| 2025-08-01 | Morgan Stanley | $312.0000 | $405 | Equal-Weight |
| 2025-08-01 | Scotiabank | $342.00 | $450.0000 | Sector Outperform |
| 2025-07-31 | Needham | $377.0000 | $478.0000 | Buy |
| 2025-07-29 | Raymond James | $308.0000 | $370.0000 | Outperform |
| 2025-07-21 | Truist Securities | $385.0000 | Buy |
Alnylam Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-05-29 | $306.09 | 0.34% |
| 2026-06-01 | $305.64 | -0.14% |
| 2026-06-02 | $295.99 | -3.16% |
| 2026-06-03 | $286.02 | -3.37% |
| 2026-06-04 | $283.91 | -0.74% |
ALNY : Long term Alnylam Pharmaceuticals stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Jun. is $318.84 , for 2027 May. is $350.65 , for 2030 May. is $578.54 , for 2031 May. is $516.78 , for 2035 May. is $151.31 , and for 2036 May. is $125.44.
ALNY : Alnylam Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jun. | $318.84 | 4.52% |
| 2026 Jul. | $321.50 | 0.84% |
| 2026 Aug. | $317.34 | -1.29% |
| 2026 Sep. | $308.36 | -2.83% |
| 2026 Oct. | $300.70 | -2.48% |
| 2026 Nov. | $300.10 | -0.20% |
| 2026 Dec. | $308.48 | 2.79% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $323.59 | 4.90% |
| 2027 Feb. | $338.37 | 4.57% |
| 2027 Mar. | $346.14 | 2.30% |
| 2027 Apr. | $349.75 | 1.04% |
| 2027 May. | $350.65 | 0.26% |
| 2027 Jun. | $355.92 | 1.50% |
| 2027 Jul. | $367.74 | 3.32% |
| 2027 Aug. | $383.42 | 4.27% |
| 2027 Sep. | $398.35 | 3.89% |
| 2027 Oct. | $407.77 | 2.36% |
| 2027 Nov. | $410.49 | 0.67% |
| 2027 Dec. | $409.81 | -0.17% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $409.53 | -0.07% |
| 2028 Feb. | $411.89 | 0.57% |
| 2028 Mar. | $416.76 | 1.18% |
| 2028 Apr. | $423.87 | 1.71% |
| 2028 May. | $432.09 | 1.94% |
| 2028 Jun. | $439.76 | 1.78% |
| 2028 Jul. | $446.57 | 1.55% |
| 2028 Aug. | $453.73 | 1.60% |
| 2028 Sep. | $462.55 | 1.94% |
| 2028 Oct. | $473.05 | 2.27% |
| 2028 Nov. | $483.12 | 2.13% |
| 2028 Dec. | $488.36 | 1.09% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $494.87 | 1.33% |
| 2029 Feb. | $500.36 | 1.11% |
| 2029 Mar. | $503.29 | 0.59% |
| 2029 Apr. | $505.65 | 0.47% |
| 2029 May. | $509.78 | 0.82% |
| 2029 Jun. | $515.82 | 1.19% |
| 2029 Jul. | $522.98 | 1.39% |
| 2029 Aug. | $530.06 | 1.35% |
| 2029 Sep. | $536.33 | 1.18% |
| 2029 Oct. | $541.76 | 1.01% |
| 2029 Nov. | $547.43 | 1.05% |
| 2029 Dec. | $552.92 | 1.00% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $559.53 | 1.20% |
| 2030 Feb. | $565.09 | 0.99% |
| 2030 Mar. | $569.52 | 0.78% |
| 2030 Apr. | $573.29 | 0.66% |
| 2030 May. | $578.54 | 0.92% |
| 2030 Jun. | $588.77 | 1.77% |
| 2030 Jul. | $597.57 | 1.50% |
| 2030 Aug. | $600.89 | 0.55% |
| 2030 Sep. | $599.22 | -0.28% |
| 2030 Oct. | $594.86 | -0.73% |
| 2030 Nov. | $589.29 | -0.94% |
| 2030 Dec. | $583.16 | -1.04% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $576.49 | -1.14% |
| 2031 Feb. | $570.05 | -1.12% |
| 2031 Mar. | $562.05 | -1.40% |
| 2031 Apr. | $546.43 | -2.78% |
| 2031 May. | $516.78 | -5.42% |
| 2031 Jun. | $470.92 | -8.88% |
| 2031 Jul. | $418.37 | -11.16% |
| 2031 Aug. | $385.69 | -7.81% |
| 2031 Sep. | $373.13 | -3.26% |
| 2031 Oct. | $370.89 | -0.60% |
| 2031 Nov. | $373.72 | 0.76% |
| 2031 Dec. | $384.01 | 2.76% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $402.39 | 4.78% |
| 2032 Feb. | $419.83 | 4.33% |
| 2032 Mar. | $429.74 | 2.36% |
| 2032 Apr. | $432.30 | 0.60% |
| 2032 May. | $430.00 | -0.53% |
| 2032 Jun. | $425.02 | -1.16% |
| 2032 Jul. | $418.34 | -1.57% |
| 2032 Aug. | $409.99 | -2.00% |
| 2032 Sep. | $397.49 | -3.05% |
| 2032 Oct. | $383.99 | -3.40% |
| 2032 Nov. | $373.43 | -2.75% |
| 2032 Dec. | $365.94 | -2.01% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $360.88 | -1.38% |
| 2033 Feb. | $359.19 | -0.47% |
| 2033 Mar. | $360.50 | 0.37% |
| 2033 Apr. | $361.78 | 0.36% |
| 2033 May. | $360.81 | -0.27% |
| 2033 Jun. | $357.08 | -1.03% |
| 2033 Jul. | $350.72 | -1.78% |
| 2033 Aug. | $341.70 | -2.57% |
| 2033 Sep. | $327.89 | -4.04% |
| 2033 Oct. | $310.44 | -5.32% |
| 2033 Nov. | $293.42 | -5.48% |
| 2033 Dec. | $278.34 | -5.14% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $265.32 | -4.68% |
| 2034 Feb. | $253.25 | -4.55% |
| 2034 Mar. | $241.93 | -4.47% |
| 2034 Apr. | $231.68 | -4.23% |
| 2034 May. | $222.91 | -3.78% |
| 2034 Jun. | $215.60 | -3.28% |
| 2034 Jul. | $209.77 | -2.71% |
| 2034 Aug. | $205.23 | -2.16% |
| 2034 Sep. | $201.67 | -1.74% |
| 2034 Oct. | $198.77 | -1.43% |
| 2034 Nov. | $196.50 | -1.14% |
| 2034 Dec. | $194.65 | -0.94% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $191.37 | -1.68% |
| 2035 Feb. | $187.52 | -2.01% |
| 2035 Mar. | $177.78 | -5.19% |
| 2035 Apr. | $164.03 | -7.74% |
| 2035 May. | $151.31 | -7.75% |
| 2035 Jun. | $142.44 | -5.86% |
| 2035 Jul. | $136.75 | -3.99% |
| 2035 Aug. | $132.98 | -2.76% |
| 2035 Sep. | $130.31 | -2.01% |
| 2035 Oct. | $128.43 | -1.44% |
| 2035 Nov. | $127.23 | -0.94% |
| 2035 Dec. | $126.56 | -0.53% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $126.26 | -0.23% |
| 2036 Feb. | $126.14 | -0.10% |
| 2036 Mar. | $126.11 | -0.03% |
| 2036 Apr. | $125.85 | -0.21% |
| 2036 May. | $125.44 | -0.32% |
Financial Data for Alnylam Pharmaceuticals stock
Frequently Asked Questions about Alnylam Pharmaceuticals stock forecast
Is Alnylam Pharmaceuticals a good long term stock?
From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock can be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2026 Jun. is $318.836242139242 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock can be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2027 May. is $350.647007779175 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock can be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2030 May. is $578.541314382135 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock can be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2031 May. is $516.783552942597 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2035 May. is $151.311037108062 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2036 May. is $125.44245992305
Is Alnylam Pharmaceuticals stock overvalued?
Alnylam Pharmaceuticals (ALNY) stock is expected to go UP . Therefore, AIPickup would say that Alnylam Pharmaceuticals (ALNY) stock is NOT overvalued.
Will Alnylam Pharmaceuticals stock price go up?
Yes. The Alnylam Pharmaceuticals stock price forecast for 2027 May. is $350.647007779175
Is Alnylam Pharmaceuticals stock a good buy now?
Since closing price on 2026-05-28 is $305.059997558594 and forecast for 2027 May. is $350.65, Alnylam Pharmaceuticals stock is a good 1 year investment.
14 Days Historical Data for Alnylam Pharmaceuticals stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| ALNY stock price for 2026-05-08 | $295.05 | $295.91 | $293.06 | $300.17 |
| ALNY stock price for 2026-05-11 | $284.84 | $294.15 | $284.28 | $296.37 |
| ALNY stock price for 2026-05-12 | $292.03 | $288.66 | $286.73 | $295.86 |
| ALNY stock price for 2026-05-13 | $291.48 | $290.70 | $288.56 | $298.38 |
| ALNY stock price for 2026-05-14 | $293.45 | $290.72 | $287.51 | $297.00 |
| ALNY stock price for 2026-05-15 | $286.98 | $294.78 | $286.76 | $298.00 |
| ALNY stock price for 2026-05-18 | $286.27 | $287.14 | $285.26 | $291.97 |
| ALNY stock price for 2026-05-19 | $294.30 | $289.00 | $284.38 | $294.93 |
| ALNY stock price for 2026-05-20 | $298.48 | $297.80 | $292.10 | $300.08 |
| ALNY stock price for 2026-05-21 | $300.51 | $296.64 | $293.00 | $301.43 |
| ALNY stock price for 2026-05-22 | $297.45 | $299.12 | $294.99 | $303.33 |
| ALNY stock price for 2026-05-26 | $295.50 | $299.00 | $294.26 | $301.09 |
| ALNY stock price for 2026-05-27 | $295.63 | $293.40 | $292.91 | $299.98 |
| ALNY stock price for 2026-05-28 | $305.06 | $293.00 | $292.77 | $305.97 |